We observed that IL‐33 monotherapy did not potently induce MM cell apoptosis, while IL‐33 treatment markedly increased the cytotoxicity of BTZ in MM cells (Figure 3J–L). This evidence concerns the gene IL33 and Miyoshi myopathy.